Products in Development
The NanOlogy therapeutic platform is composed of patented large surface area microparticles (LSAMs) of pure drug designed for tumor-directed therapy via intratumoral, peritoneal, intravesicular, inhalation, and other routes of local administration.
NanoPac®
(LSAM Paclitaxel) for Suspension
Ovarian Cancer (intraperitoneal)
Prostate Cancer (intratumoral)
Pancreatic Cancer (intratumoral)
Pancreatic Mucinous Cysts (intracystic)
Lung Cancer (intratumoral/nodal)
NanoDoce®
(LSAM Docetaxel) for Suspension
Bladder Cancer (resection bed injection)
Renal Cancer (intratumoral)
NanoPac®
(LSAM Paclitaxel) for Nebulized Inhalation
Lung Cancer (inhalation)
SOR007
(Topical Submicron Particle Paclitaxel Suspended in Anhydrous Base)
Cutaneous Metastases
Actinic Keratosis
